| Literature DB >> 28434650 |
Adeera Levin1, Marcello Tonelli2, Joseph Bonventre3, Josef Coresh4, Jo-Ann Donner5, Agnes B Fogo6, Caroline S Fox7, Ron T Gansevoort8, Hiddo J L Heerspink9, Meg Jardine10, Bertram Kasiske11, Anna Köttgen12, Matthias Kretzler13, Andrew S Levey14, Valerie A Luyckx15, Ravindra Mehta16, Orson Moe17, Gregorio Obrador18, Neesh Pannu19, Chirag R Parikh20, Vlado Perkovic21, Carol Pollock22, Peter Stenvinkel23, Katherine R Tuttle24, David C Wheeler25, Kai-Uwe Eckardt26.
Abstract
The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5-10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury-a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.Entities:
Mesh:
Year: 2017 PMID: 28434650 DOI: 10.1016/S0140-6736(17)30788-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321